Orange Book product · Generic (ANDA)
FOSAMPRENAVIR CALCIUM
FOSAMPRENAVIR CALCIUM
Generic (ANDA)ANDA 204024TE ABRX SUN PHARM
At a glance
Nov 20, 2019
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 20, 2019
6 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
FOSAMPRENAVIR CALCIUM
Strength
EQ 700MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 204024
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FOSAMPRENAVIR CALCIUM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
